← Back to Search

Prebiotic

Single Arm for Parkinson's Disease

N/A
Waitlist Available
Led By Deborah A Hall, MD PhD
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 days
Awards & highlights

Study Summary

Prebiotics in the Parkinson's Disease Microbiome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tolerability of prebiotic bar after 10 days in PD participants
Secondary outcome measures
Safety of prebiotic bar during 10 days in Parkinson's disease participants
Other outcome measures
Changes in PD related gastrointestinal symptoms
Changes in brain health
Intestines
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single ArmExperimental Treatment1 Intervention
Open-label consumption of prebiotic bar(s); 1 bar for 3 days; followed by 2 bars for 7 days

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
422 Previous Clinical Trials
163,481 Total Patients Enrolled
Deborah A Hall, MD PhDPrincipal InvestigatorRush University Medical Center
1 Previous Clinical Trials
10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025